Dissemin is shutting down on January 1st, 2025

Published in

Nature Research, Nature Medicine, 10(29), p. 2509-2517, 2023

DOI: 10.1038/s41591-023-02542-x

Links

Tools

Export citation

Search in Google Scholar

Viral genetic clustering and transmission dynamics of the 2022 mpox outbreak in Portugal

Journal article published in 2023 by Vítor Borges, Mariana Perez Duque ORCID, João Vieira Martins, Paula Vasconcelos, Rita Ferreira, Daniel Sobral ORCID, Ana Pelerito, Isabel Lopes de Carvalho, Maria Sofia Núncio ORCID, Maria José Borrego, Cornelius Roemer ORCID, Richard A. Neher ORCID, Megan O’Driscoll ORCID, Raquel Rocha, Sílvia Lopo and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractPathogen genome sequencing during epidemics enhances our ability to identify and understand suspected clusters and investigate their relationships. Here, we combine genomic and epidemiological data of the 2022 mpox outbreak to better understand early viral spread, diversification and transmission dynamics. By sequencing 52% of the confirmed cases in Portugal, we identified the mpox virus sublineages with the highest impact on case numbers and fitted them into a global context, finding evidence that several international sublineages probably emerged or spread early in Portugal. We estimated a 62% infection reporting rate and that 1.3% of the population of men who have sex with men in Portugal were infected. We infer the critical role played by sexual networks and superspreader gatherings, such as sauna attendance, in the dissemination of mpox virus. Overall, our findings highlight genomic epidemiology as a tool for the real-time monitoring and control of mpox epidemics, and can guide future vaccine policy in a highly susceptible population.